Dedinje FFR/QFR Registry
- Conditions
- Coronary Artery Disease (CAD)Fractional Flow Reserve
- Registration Number
- NCT06659367
- Lead Sponsor
- Institute for Cardiovascular Diseases Dedinje
- Brief Summary
Quantitative Flow Ratio (QFR) has shown good diagnostic performance against Fractional Flow Reserve (FFR) in several meta-analyses, comparable or even superior to nonhyperemic pressure ratios. However, the reproducibility of QFR is modest and there is high inter- and intra-observer variability even when fairly experienced but non-core lab operators (at least 150 QFR procedure experience) are performing the analysis. Although smaller studies have demonstrated that non-core analysis and even paramedical user analysis can have good correlation with FFR, the concern about the diagnostic performance of QFR in real-world clinical practice by inexperienced users remains.
The primary objective of "Dedinje FFR/QFR Registry" is to determine the feasibility and diagnostic performance of QFR analysis by vendor-certified inexperienced medical users in a real-world setting using FFR as the gold standard. All patients \>18 years old who present to the Institute for Cardiovascular Diseases "Dedinje" and undergo a planned or ad hoc FFR procedure will be asked to participate in the registry. FFR procedure is performed according to the standardized institutional protocol. QFR analysis will be subsequently performed offline according to a standard operating procedure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2500
- >18 years old
- Had a clinically indicated FFR procedure performed (either as a planned procedure or ad hoc)
- Declines to participate in the registry and provide informed consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation between Quantitative Flow Ratio (QFR) and Fractional Flow Reserve (FFR) at the time of Quantitative Flow Ratio (QFR) analysis completion (up to 1 year) correlation coefficient (r) between Quantitative Flow Ratio (QFR) and Fractional Flow Reserve (FFR)
Sensitivity of Quantitative Flow Ratio (QFR) at the time of Quantitative Flow Ratio (QFR) analysis completion (up to 1 year) Sensitivity of Quantitative Flow Ratio (QFR) against Fractional Flow Reserve (FFR) as the gold standard
Specificity of Quantitative Flow Ratio (QFR) at the time of Quantitative Flow Ratio (QFR) analysis completion (up to 1 year) Specificity of Quantitative Flow Ratio (QFR) against Fractional Flow Reserve (FFR) as the gold standard
Positive predictive value of Quantitative Flow Ratio (QFR) at the time of Quantitative Flow Ratio (QFR) analysis completion (up to 1 year) Positive predictive value of Quantitative Flow Ratio (QFR) against Fractional Flow Reserve (FFR) as the gold standard
Negative predictive value of Quantitative Flow Ratio (QFR) at the time of Quantitative Flow Ratio (QFR) analysis completion (up to 1 year) Negative predictive value of Quantitative Flow Ratio (QFR) against Fractional Flow Reserve (FFR) as the gold standard
Diagnostic gray zone at the time of Quantitative Flow Ratio (QFR) analysis completion (up to 1 year) Quantitative Flow Ratio (QFR) limits for achieving 95% sensitivity and specificity in comparison to Fractional Flow Reserve (FFR)
Diagnostic accuracy of Quantitative Flow Ratio (QFR) against Fractional Flow Reserve (FFR) at the time of Quantitative Flow Ratio (QFR) analysis completion (up to 1 year) Area under the curve (using cutoff values of \<=0.80 for both methods)
- Secondary Outcome Measures
Name Time Method Diagnostic performance of nonhyperemic pressure ratios and 3-dimensional Quantitative Coronary Angiography (3D-QCA) against Fractional Flow Reserve (FFR) as the gold standard at the time of Quantitative Flow Ratio (QFR) analysis completion (up to 1 year) Sensitivity, specificity, positive predictive value and negative predictive value of nonhyperemic pressure ratios and 3-dimensional Quantitative Coronary Angiography (3D-QCA) against Fractional Flow Reserve (FFR)
Diagnostic accuracy of nonhyperemic pressure ratios and 3-dimensional Quantitative Coronary Angiography (3D-QCA) against Fractional Flow Reserve (FFR) as the gold standard at the time of Quantitative Flow Ratio (QFR) analysis completion (up to 1 year) Area under the curve (using cutoff values of \<=0.89 for nonhyperemic pressure ratios and \>=50% diameter stenosis for 3-dimensional Quantitative Coronary Angiography (3D-QCA)) against Fractional Flow Reserve (FFR, cutoff value \<=0.80)
Inter-observer variability at the time of Quantitative Flow Ratio (QFR) analysis completion (up to 1 year) Coefficient of variation for repeated Quantitative Flow Ratio (QFR) computation between users, standard deviation for repeated Quantitative Flow Ratio (QFR) measurements between users, binary diagnostic classification agreement between users
Intra-observer variability at the time of Quantitative Flow Ratio (QFR) analysis completion (up to 1 year) Coefficient of variation for repeated Quantitative Flow Ratio (QFR) computation within users, standard deviation for repeated Quantitative Flow Ratio (QFR) measurements within users, binary diagnostic classification agreement within users
All-cause death at 6 months, 1 year and annually for 5 years All-cause death
Myocardial infarction at 6 months, 1 year and annually for 5 years Myocardial infarction
Vessel-oriented composite outcome at 6 months, 1 year and annually for 5 years Cardiac death, vessel-related myocardial infarction and ischemia-driven target vessel revascularization
Change in Seattle Angina Questionnaire-7 Items Score (SAQ-7) at 6 months 6 months Change in Seattle Angina Questionnaire-7 Items Score (SAQ-7) at 6 months from the time of the Fractional Flow Reserve (FFR) procedure. (scale 0-100, 100 = full health, 0 = worst health)
Change in EuroQol-5 Dimensions- 5 Levels (EQ-5D-5L) Score 6 months Change in EuroQol-5 Dimensions- 5 Levels (EQ-5D-5L) Score at 6 months from the time of the Fractional Flow Reserve (FFR) procedure (scale 5-25, 5= no problems in any dimension, 25= extreme problems on all dimensions; visual analogue scale 0-100, 0= worst health possible, 100= best health possible)
Trial Locations
- Locations (1)
Institute for Cardiovascular Diseases "Dedinje"
🇷🇸Belgrade, Serbia